Loading...

Scott Vandenberg, MD, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPathology
Address2340 Sutter Street
San Francisco CA 94115
Phone415-514-4978
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Duke UniversityB.S.1972Zoology
    Stanford UniversityM.D.1979Medicine
    Stanford UniversityPh.D.1979Bio & Behavioral Neurosciences

    Collapse Research 
    Collapse Research Activities and Funding
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS R01NS022455Apr 15, 1986 - Mar 31, 1990
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    MONOAMINES IN EMBRYONAL CNS TUMOR DIFFERENTIATION
    NIH/NINDS K07NS000854Jul 1, 1984 - Jun 30, 1989
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator
    NEUROPATHOLOGY RESEARCH
    NIH/NINDS T32NS007236Jul 1, 1983 - Jun 30, 1993
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. van Draanen J, Davidson P, Bour-Jordan H, Bowman-Carpio L, Boyle D, Dubinett S, Gardner B, Gardner J, McFall C, Mercola D, Nakazono T, Soares S, Stoppler H, Tempero M, Vandenberg S, Wan YY, Dry S. Assessing Researcher Needs for a Virtual Biobank. Biopreserv Biobank. 2016 Dec 08. PMID: 27929677.
      View in: PubMed
    2. Sheth V, Shao H, Chen J, Vandenberg S, Corey-Bloom J, Bydder GM, Du J. Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies. Neuroimage. 2016 Aug 1; 136:37-44. PMID: 27155128.
      View in: PubMed
    3. van Vugt VA, Kesari A, Muller KA, Carter B, Vandenberg SR, Kesari S. A 22-Year Old Woman with Right Eyelid Swelling. Brain Pathol. 2016 May; 26(3):425-6. PMID: 27111386.
      View in: PubMed
    4. Jones KA, Gilder AS, Lam MS, Du N, Banki MA, Merati A, Pizzo DP, VandenBerg SR, Gonias SL. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro Oncol. 2016 May; 18(5):667-78. PMID: 26420897.
      View in: PubMed
    5. Barajas RF, Phillips JJ, Vandenberg S, McDermott MW, Berger MS, Dillon WP, Cha S. Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI. Clin Radiol. 2015 Oct; 70(10):1087-95. PMID: 26231469.
      View in: PubMed
    6. Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon CH, Saya H, Nakano I, Pizzo DP, VandenBerg SR, Chen CC. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proc Natl Acad Sci U S A. 2015 Jul 28; 112(30):E4055-64. PMID: 26159421; PMCID: PMC4522819 [Available on 01/28/16].
    7. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg S, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98. PMID: 26061751; PMCID: PMC4530011 [Available on 12/25/15].
    8. Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Res. 2015 Jan 15; 75(2):394-404. PMID: 25432173; PMCID: PMC4297573 [Available on 01/15/16].
    9. Hu J, Muller KA, Furnari FB, Cavenee WK, VandenBerg SR, Gonias SL. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. Oncogene. 2015 Jul 30; 34(31):4078-88. PMID: 25347738; PMCID: PMC4411189 [Available on 01/30/16].
    10. Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen CC. Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget. 2014 Sep 15; 5(17):7342-56. PMID: 25277177; PMCID: PMC4202127.
    11. Farid N, Almeida-Freitas DB, White NS, McDonald CR, Kuperman JM, Almutairi AA, Muller KA, VandenBerg SR, Kesari S, Dale AM. Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria). J Neurooncol. 2014 Dec; 120(3):539-46. PMID: 25135423.
      View in: PubMed
    12. Hartman LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM, Hasenauer B, VandenBerg SR, MacDonald TJ, Durden DL. Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors. J Pediatr Hematol Oncol. 2014 Aug; 36(6):451-7. PMID: 24309609; PMCID: PMC4356196.
    13. Northcott PA, Lee C, Zichner T, Stütz AM, Erkek S, Kawauchi D, Shih DJ, Hovestadt V, Zapatka M, Sturm D, Jones DT, Kool M, Remke M, Cavalli FM, Zuyderduyn S, Bader GD, VandenBerg S, Esparza LA, Ryzhova M, Wang W, Wittmann A, Stark S, Sieber L, Seker-Cin H, Linke L, Kratochwil F, Jäger N, Buchhalter I, Imbusch CD, Zipprich G, Raeder B, Schmidt S, Diessl N, Wolf S, Wiemann S, Brors B, Lawerenz C, Eils J, Warnatz HJ, Risch T, Yaspo ML, Weber UD, Bartholomae CC, von Kalle C, Turányi E, Hauser P, Sanden E, Darabi A, Siesjö P, Sterba J, Zitterbart K, Sumerauer D, van Sluis P, Versteeg R, Volckmann R, Koster J, Schuhmann MU, Ebinger M, Grimes HL, Robinson GW, Gajjar A, Mynarek M, von Hoff K, Rutkowski S, Pietsch T, Scheurlen W, Felsberg J, Reifenberger G, Kulozik AE, von Deimling A, Witt O, Eils R, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Korbel JO, Wechsler-Reya RJ, Pfister SM. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 2014 Jul 24; 511(7510):428-34. PMID: 25043047; PMCID: PMC4201514.
    14. Mahta A, Borys E, Vandenberg S, Carter B, Kesari S. 72 year old female with leg weakness. Brain Pathol. 2014 Mar; 24(2):195-6. PMID: 25121191.
      View in: PubMed
    15. Du J, Ma G, Li S, Carl M, Szeverenyi NM, VandenBerg S, Corey-Bloom J, Bydder GM. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 2014 Feb 15; 87:32-41. PMID: 24188809; PMCID: PMC4091919.
    16. Mahta A, Du Z, Borys E, Carter B, Vandenberg S, Kesari S. 78 year old male with dysphagia and dysarthria. Brain Pathol. 2013 Nov; 23(6):705-6. PMID: 24118489.
      View in: PubMed
    17. Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg S, Yeo GW, Fu XD, Bennett CF, Cleveland DW, Ravits J. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):E4530-9. PMID: 24170860; PMCID: PMC3839752.
    18. Farid N, Almeida-Freitas DB, White NS, McDonald CR, Muller KA, Vandenberg S, Kesari S, Dale AM. Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM. Front Oncol. 2013; 3:258. PMID: 24137566; PMCID: PMC3786386.
    19. Garmy-Susini B, Avraamides CJ, Desgrosellier JS, Schmid MC, Foubert P, Ellies LG, Lowy AM, Blair SL, Vandenberg S, Datnow B, Wang HY, Cheresh DA, Varner J. PI3Ka activates integrin a4ß1 to establish a metastatic niche in lymph nodes. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):9042-7. PMID: 23671068; PMCID: PMC3670313.
    20. Staudt ND, Jo M, Hu J, Bristow JM, Pizzo DP, Gaultier A, VandenBerg SR, Gonias SL. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Res. 2013 Jul 1; 73(13):3902-12. PMID: 23633492; PMCID: PMC3702673.
    21. Li N, Wu X, Holzer RG, Lee JH, Todoric J, Park EJ, Ogata H, Gukovskaya AS, Gukovsky I, Pizzo DP, VandenBerg S, Tarin D, Atay C, Arkan MC, Deerinck TJ, Moscat J, Diaz-Meco M, Dawson D, Erkan M, Kleeff J, Karin M. Loss of acinar cell IKKa triggers spontaneous pancreatitis in mice. J Clin Invest. 2013 May; 123(5):2231-43. PMID: 23563314; PMCID: PMC3635720.
    22. Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg S, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, Furnari FB, Thomas JB. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. PLoS Genet. 2013; 9(2):e1003253. PMID: 23459592; PMCID: PMC3573097.
    23. Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL. Role of connexins in metastatic breast cancer and melanoma brain colonization. J Cell Sci. 2013 Feb 15; 126(Pt 4):904-13. PMID: 23321642; PMCID: PMC3625812.
    24. Silber J, Hashizume R, Felix T, Hariono S, Yu M, Berger MS, Huse JT, VandenBerg SR, James CD, Hodgson JG, Gupta N. Expression of miR-124 inhibits growth of medulloblastoma cells. Neuro Oncol. 2013 Jan; 15(1):83-90. PMID: 23172372; PMCID: PMC3534424.
    25. Udaka YT, Yeh-Nayre LA, Amene CS, VandenBerg SR, Levy ML, Crawford JR. Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children. J Neurosurg Pediatr. 2013 Feb; 11(2):119-26. PMID: 23157391.
      View in: PubMed
    26. Fenton TR, Nathanson D, Ponte de Albuquerque C, Kuga D, Iwanami A, Dang J, Yang H, Tanaka K, Oba-Shinjo SM, Uno M, Inda MM, Wykosky J, Bachoo RM, James CD, DePinho RA, Vandenberg S, Zhou H, Marie SK, Mischel PS, Cavenee WK, Furnari FB. Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14164-9. PMID: 22891331; PMCID: PMC3435194.
    27. Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK, Furnari FB. EGFRvIII promotes glioma angiogenesis and growth through the NF-?B, interleukin-8 pathway. Oncogene. 2012 Sep 6; 31(36):4054-66. PMID: 22139077; PMCID: PMC3537826.
    28. Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, Kesari S, Meyerson M. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Res. 2011 Dec 15; 71(24):7587-96. PMID: 22001862; PMCID: PMC3242822.
    29. Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, Weiss WA, Petritsch C. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011 Sep 13; 20(3):328-40. PMID: 21907924; PMCID: PMC3297490.
    30. Hu J, Jo M, Cavenee WK, Furnari F, VandenBerg SR, Gonias SL. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proc Natl Acad Sci U S A. 2011 Sep 20; 108(38):15984-9. PMID: 21896743; PMCID: PMC3179096.
    31. Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec; 13(12):1331-8. PMID: 21896554; PMCID: PMC3223090.
    32. Khayal IS, Vandenberg S, Smith KJ, Cloyd CP, Chang SM, Cha S, Nelson SJ, McKnight TR. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro Oncol. 2011 Nov; 13(11):1192-201. PMID: 21865401; PMCID: PMC3199150.
    33. Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg S, Kelsey KT, Berger MS, Wiencke JK. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro Oncol. 2011 Mar; 13(3):280-9. PMID: 21339190; PMCID: PMC3064601.
    34. Nakamura JL, Phong C, Pinarbasi E, Kogan SC, Vandenberg S, Horvai AE, Faddegon BA, Fiedler D, Shokat K, Houseman BT, Chao R, Pieper RO, Shannon K. Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. Cancer Res. 2011 Jan 1; 71(1):106-15. PMID: 21199799; PMCID: PMC3077533.
    35. Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol. 2011 Sep; 104(2):423-38. PMID: 21193945; PMCID: PMC3161192.
    36. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. The genetic landscape of the childhood cancer medulloblastoma. Science. 2011 Jan 28; 331(6016):435-9. PMID: 21163964; PMCID: PMC3110744.
    37. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg S, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010 Dec 14; 18(6):669-82. PMID: 21156288; PMCID: PMC3031116.
    38. Reyes NA, Fisher JK, Austgen K, VandenBerg S, Huang EJ, Oakes SA. Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J Clin Invest. 2010 Oct; 120(10):3673-9. PMID: 20890041; PMCID: PMC2947232.
    39. Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, Brennan C, Johns TG, Bachoo R, Hadwiger P, Tan P, Depinho RA, Cavenee W, Furnari F. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 2010 Aug 15; 24(16):1731-45. PMID: 20713517; PMCID: PMC2922502.
    40. Srinivasan R, Phillips JJ, Vandenberg S, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ. Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro Oncol. 2010 Nov; 12(11):1152-61. PMID: 20647244; PMCID: PMC3098023.
    41. Raja AS, Propper BW, Vandenberg SL, Matchette MW, Rasmussen TE, Johannigman JA, Davidson SB. Imaging utilization during explosive multiple casualty incidents. J Trauma. 2010 Jun; 68(6):1421-4. PMID: 20539185.
      View in: PubMed
    42. Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Nguyen K, Yakovenko S, Zhe XN, Gilmer HC, Collins R, Nagaoka M, Phillips JJ, Jenkins RB, Tihan T, Vandenberg S, James CD, Tanaka K, Taylor MD, Weiss WA, Chesler L. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 2010 May 15; 24(10):1059-72. PMID: 20478998; PMCID: PMC2867210.
    43. Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R. Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagn Pathol. 2010; 5:26. PMID: 20420692; PMCID: PMC2867958.
    44. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010 Apr 13; 17(4):362-75. PMID: 20385361.
      View in: PubMed
    45. Barajas RF, Hodgson JG, Chang JS, Vandenberg S, Yeh RF, Parsa AT, McDermott MW, Berger MS, Dillon WP, Cha S. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology. 2010 Feb; 254(2):564-76. PMID: 20093527; PMCID: PMC2809924.
    46. Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg S, James CD, Nelson SJ. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol. 2010 Feb; 12(2):133-44. PMID: 20150380; PMCID: PMC2940577.
    47. Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley MY, Yu M, Fisher PG, Rowitch DH, Ford JM, Berger MS, Ji H, Gutmann DH, James CD. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 2010 Jan 15; 70(2):512-9. PMID: 20068183; PMCID: PMC2851233.
    48. Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro Oncol. 2010 Apr; 12(4):366-76. PMID: 20308314; PMCID: PMC2940601.
    49. Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2009 Dec; 11(6):842-52. PMID: 19229057; PMCID: PMC2802404.
    50. Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol. 2009 Dec; 2(4):271-80. PMID: 19956389; PMCID: PMC2781083.
    51. Tate MC, Banerjee A, Vandenberg S, Tihan T, Chi JH, Ames CP, Parsa AT. Post-radiation reactive changes in a single vertebral body mimicking metastatic pineoblastoma. J Neurosurg Pediatr. 2009 Nov; 4(5):479-83. PMID: 19877784.
      View in: PubMed
    52. McBride SM, Perez DA, Polley MY, Vandenberg S, Smith JS, Zheng S, Lamborn KR, Wiencke JK, Chang SM, Prados MD, Berger MS, Stokoe D, Haas-Kogan DA. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. J Neurooncol. 2010 Mar; 97(1):33-40. PMID: 19705067; PMCID: PMC2814032.
    53. Khayal IS, McKnight TR, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed. 2009 May; 22(4):449-55. PMID: 19125391; PMCID: PMC3772178.
    54. Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol. 2009 May; 92(3):401-15. PMID: 19357966; PMCID: PMC2834319.
    55. Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, Spellman PT, Vandenberg S, Berger MS, James CD. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro Oncol. 2009 Oct; 11(5):477-87. PMID: 19139420; PMCID: PMC2765338.
    56. Dinca EB, Lu KV, Sarkaria JN, Pieper RO, Prados MD, Haas-Kogan DA, Vandenberg S, Berger MS, James CD. p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts. Cancer Res. 2008 Dec 15; 68(24):10034-9. PMID: 19074867; PMCID: PMC2987557.
    57. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 1; 27(4):579-84. PMID: 19075262; PMCID: PMC2645859.
    58. Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia. 2008 Nov; 10(11):1204-12. PMID: 18953429; PMCID: PMC2570596.
    59. Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 2008 Jul; 18(3):307-16. PMID: 18532929.
      View in: PubMed
    60. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg S, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008; 6:14. PMID: 18577219; PMCID: PMC2443372.
    61. Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008 Jun; 10(3):254-64. PMID: 18359864; PMCID: PMC2563048.
    62. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008 Mar 10; 26(8):1338-45. PMID: 18323558.
      View in: PubMed
    63. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008 Mar; 13(3):206-20. PMID: 18328425; PMCID: PMC2643426.
    64. Krauze MT, Vandenberg S, Yamashita Y, Saito R, Forsayeth J, Noble C, Park J, Bankiewicz KS. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Exp Neurol. 2008 Apr; 210(2):638-44. PMID: 18295759; PMCID: PMC2362104.
    65. Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, VandenBerg SR, Lal A. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008 Apr; 18(2):172-9. PMID: 18093250.
      View in: PubMed
    66. Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg S, Lal A. Molecular signatures define two main classes of meningiomas. Mol Cancer. 2007; 6:64. PMID: 17937814; PMCID: PMC2173907.
    67. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007 Oct; 9(4):424-9. PMID: 17622647; PMCID: PMC1994099.
    68. Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007 Jul; 9(3):271-9. PMID: 17504928; PMCID: PMC1907411.
    69. Entin-Meer M, Yang X, VandenBerg SR, Lamborn KR, Nudelman A, Rephaeli A, Haas-Kogan DA. In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas. Neuro Oncol. 2007 Apr; 9(2):82-8. PMID: 17347490; PMCID: PMC1871664.
    70. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg S, Lamborn KR, Lal A. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res. 2007 Jan 1; 13(1):68-75. PMID: 17200340.
      View in: PubMed
    71. Cadieux B, Ching TT, VandenBerg SR, Costello JF. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 2006 Sep 1; 66(17):8469-76. PMID: 16951158.
      View in: PubMed
    72. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 2006 Jul 20; 51(2):187-99. PMID: 16846854.
      View in: PubMed
    73. Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006 Jun; 78(2):113-21. PMID: 16554968.
      View in: PubMed
    74. Entin-Meer M, Rephaeli A, Yang X, Nudelman A, VandenBerg SR, Haas-Kogan DA. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Mol Cancer Ther. 2005 Dec; 4(12):1952-61. PMID: 16373710.
      View in: PubMed
    75. Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 2005 Nov; 57(5):1041-7; discussion 1041-7. PMID: 16284574.
      View in: PubMed
    76. Swerdlow RH, Redpath GT, Binder DR, Davis JN, VandenBerg SR. Mitochondrial DNA depletion analysis by pseudogene ratioing. J Neurosci Methods. 2006 Jan 30; 150(2):265-71. PMID: 16118020.
      View in: PubMed
    77. Salasznyk RM, Westcott AM, Klees RF, Ward DF, Xiang Z, Vandenberg S, Bennett K, Plopper GE. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells Dev. 2005 Aug; 14(4):354-66. PMID: 16137224.
      View in: PubMed
    78. Rola R, Otsuka S, Obenaus A, Nelson GA, Limoli CL, VandenBerg SR, Fike JR. Indicators of hippocampal neurogenesis are altered by 56Fe-particle irradiation in a dose-dependent manner. Radiat Res. 2004 Oct; 162(4):442-6. PMID: 15447038.
      View in: PubMed
    79. Rola R, Raber J, Rizk A, Otsuka S, VandenBerg SR, Morhardt DR, Fike JR. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol. 2004 Aug; 188(2):316-30. PMID: 15246832.
      View in: PubMed
    80. Raber J, Rola R, LeFevour A, Morhardt D, Curley J, Mizumatsu S, VandenBerg SR, Fike JR. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res. 2004 Jul; 162(1):39-47. PMID: 15222778.
      View in: PubMed
    81. Ellegala DB, Kligori C, Vandenberg S, Dumont A, Shaffrey ME. Intracranial metastasis of a primary scalp angiosarcoma. Case illustration. J Neurosurg. 2002 Sep; 97(3):725. PMID: 12296666.
      View in: PubMed
    82. Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol. 2002 Apr; 26(4):479-85. PMID: 11914626.
      View in: PubMed
    83. Hussaini IM, Carpenter JE, Redpath GT, Sando JJ, Shaffrey ME, Vandenberg S. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro Oncol. 2002 Jan; 4(1):9-21. PMID: 11772428; PMCID: PMC1920632.
    84. Eberhard DA, Karns LR, VandenBerg SR, Creutz CE. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci. 2001 Sep; 114(Pt 17):3155-66. PMID: 11590242.
      View in: PubMed
    85. Mandell JW, Gocan NC, Vandenberg S. Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal. Glia. 2001 Jun; 34(4):283-95. PMID: 11360301.
      View in: PubMed
    86. Hussaini IM, Karns LR, Vinton G, Carpenter JE, Redpath GT, Sando JJ, VandenBerg SR. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. J Biol Chem. 2000 Jul 21; 275(29):22348-54. PMID: 10806212.
      View in: PubMed
    87. Mandell JW, VandenBerg SR. ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport. 1999 Nov 26; 10(17):3567-72. PMID: 10619645.
      View in: PubMed
    88. Hirano H, Lopes MB, Laws ER, Asakura T, Goto M, Carpenter JE, Karns LR, VandenBerg SR. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro Oncol. 1999 Apr; 1(2):109-19. PMID: 11550306; PMCID: PMC1920755.
    89. Hussaini IM, Brown MD, Weaver AM, Carpenter J, Karns LR, Vandenberg S, Gonias SL. Stable antisense RNA expression neutralizes the activity of low-density lipoprotein receptor-related protein and promotes urokinase accumulation in the medium of an astrocytic tumor cell line. Antisense Nucleic Acid Drug Dev. 1999 Apr; 9(2):183-90. PMID: 10355824.
      View in: PubMed
    90. Hussaini IM, Brown MD, Karns LR, Carpenter J, Redpath GT, Gonias SL, Vandenberg S. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia. 1999 Jan; 25(1):71-84. PMID: 9888299.
      View in: PubMed
    91. Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR. In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol. 1998 Nov; 153(5):1411-23. PMID: 9811332; PMCID: PMC1853399.
    92. Eberhard DA, Vandenberg S. Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins. Biochem J. 1998 Feb 15; 330 ( Pt 1):67-72. PMID: 9461492; PMCID: PMC1219109.
    93. Decaestecker C, Lopes BS, Gordower L, Camby I, Cras P, Martin JJ, Kiss R, VandenBerg SR, Salmon I. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas. J Neuropathol Exp Neurol. 1997 Apr; 56(4):391-402. PMID: 9100670.
      View in: PubMed
    94. Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, VandenBerg SR. Ganglioglioma: an ultrastructural and immunohistochemical study. Cancer. 1997 Mar 1; 79(5):989-1003. PMID: 9041162.
      View in: PubMed
    95. Brown MD, Banker GA, Hussaini IM, Gonias SL, VandenBerg SR. Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Res. 1997 Feb 7; 747(2):313-7. PMID: 9046007.
      View in: PubMed
    96. Shaffrey ME, Lanzino G, Lopes MB, Hessler RB, Kassell NF, VandenBerg SR. Maturation of intracranial immature teratomas. Report of two cases. J Neurosurg. 1996 Oct; 85(4):672-6. PMID: 8814173.
      View in: PubMed
    97. Hussaini IM, LaMarre J, Lysiak JJ, Karns LR, VandenBerg SR, Gonias SL. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta(1) in the RAW 264.7 macrophage-like cell line. J Leukoc Biol. 1996 May; 59(5):733-9. PMID: 8656060.
      View in: PubMed
    98. Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol. 1996; 91(4):368-75. PMID: 8928613.
      View in: PubMed
    99. Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Harner SG, VandenBerg SR. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995 Jul 1; 76(1):4-19. PMID: 8630875.
      View in: PubMed
    100. Moots PL, Harrison MB, Vandenberg S. Prolonged survival in carcinomatous meningitis associated with breast cancer. South Med J. 1995 Mar; 88(3):357-62. PMID: 7886538.
      View in: PubMed
    101. Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Hukee MJ, VandenBerg SR, Charlesworth JC. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol. 1995; 90(4):387-99. PMID: 8546029.
      View in: PubMed
    102. Eberhard DA, Brown MD, VandenBerg SR. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol. 1994 Sep; 145(3):640-9. PMID: 8080046; PMCID: PMC1890341.
    103. Sindt KA, Hewlett EL, Redpath GT, Rappuoli R, Gray LS, Vandenberg S. Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib. Infect Immun. 1994 Aug; 62(8):3108-14. PMID: 8039878; PMCID: PMC302934.
    104. Hirose T, Scheithauer BW, Lopes MB, VandenBerg SR. Dysembryoplastic neuroeptihelial tumor (DNT): an immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol. 1994 Mar; 53(2):184-95. PMID: 8120540.
      View in: PubMed
    105. Lopes MB, Bogaev CA, Gonias SL, VandenBerg SR. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. FEBS Lett. 1994 Feb 7; 338(3):301-5. PMID: 8307199.
      View in: PubMed
    106. Turner JS, Redpath GT, Humphries JE, Gonias SL, Vandenberg S. Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. Biochem J. 1994 Jan 1; 297 ( Pt 1):175-9. PMID: 8280096; PMCID: PMC1137807.
    107. VandenBerg S. Neurenteric cyst or teratomatous cyst. J Neurosurg. 1994 Jan; 80(1):181. PMID: 8271014.
      View in: PubMed
    108. Lopes MB, Gonzalez-Fernandez F, Scheithauer BW, VandenBerg SR. Differential expression of retinal proteins in a pineal parenchymal tumor. J Neuropathol Exp Neurol. 1993 Sep; 52(5):516-24. PMID: 8360704.
      View in: PubMed
    109. Wooten GF, Lopes MB, Harris WO, Reagan TJ, Vandenberg S. Pallidoluysian atrophy: dystonia and basal ganglia functional anatomy. Neurology. 1993 Sep; 43(9):1764-8. PMID: 8414028.
      View in: PubMed
    110. VandenBerg SR. Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol. 1993 Jul; 3(3):275-81. PMID: 8293187.
      View in: PubMed
    111. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993 Feb 15; 71(4):1247-53. PMID: 8435801.
      View in: PubMed
    112. Geanacopoulos M, Turner J, Bowling KE, Vandenberg S, Gear AR. The role of protein kinase C in the initial events of platelet activation by thrombin assessed with a selective inhibitor. Thromb Res. 1993 Jan 1; 69(1):113-24. PMID: 8465270.
      View in: PubMed
    113. Hessler RB, Lopes MB, Frankfurter A, Reidy J, VandenBerg SR. Cytoskeletal immunohistochemistry of central neurocytomas. Am J Surg Pathol. 1992 Nov; 16(11):1031-8. PMID: 1471723.
      View in: PubMed
    114. Malik JM, Cosgrove GR, VandenBerg SR. Remote recurrence of craniopharyngioma in the epidural space. Case report. J Neurosurg. 1992 Nov; 77(5):804-7. PMID: 1403127.
      View in: PubMed
    115. VandenBerg SR. Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol. 1992 Nov; 51(6):644-57. PMID: 1362439.
      View in: PubMed
    116. Gonzalez-Fernandez F, Lopes MB, Garcia-Fernandez JM, Foster RG, De Grip WJ, Rosemberg S, Newman SA, VandenBerg SR. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. Am J Pathol. 1992 Aug; 141(2):363-75. PMID: 1386715; PMCID: PMC1886598.
    117. Wolf BB, Lopes MB, VandenBerg SR, Gonias SL. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol. 1992 Jul; 141(1):37-42. PMID: 1632469; PMCID: PMC1886577.
    118. Britt SG, Chiu VW, Redpath GT, VandenBerg SR. Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water soluble analogue of vitamin E. J Recept Res. 1992; 12(2):181-200. PMID: 1583621.
      View in: PubMed
    119. Phillips LH, Persing JA, Vandenberg S. Electrophysiological findings in localized hypertrophic mononeuropathy. Muscle Nerve. 1991 Apr; 14(4):335-41. PMID: 1851247.
      View in: PubMed
    120. Davis RL, Kepes JJ, Rorke LB, VandenBerg SR. The art of brain tumour classification--a tribute to Lucien J. Rubinstein (1925-1990). Interview by Paul Kleihues. Brain Pathol. 1990 Sep; 1(1):55-9. PMID: 1669694.
      View in: PubMed
    121. Klein P, Zientek G, VandenBerg SR, Lothman E. Primary CNS lymphoma: lymphomatous meningitis presenting as a cauda equina lesion in an AIDS patient. Can J Neurol Sci. 1990 Aug; 17(3):329-31. PMID: 2207891.
      View in: PubMed
    122. Keohane ME, Hall SW, VandenBerg SR, Gonias SL. Secretion of alpha 2-macroglobulin, alpha 2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture. J Neurosurg. 1990 Aug; 73(2):234-41. PMID: 1694891.
      View in: PubMed
    123. Hall SW, VandenBerg SR, Gonias SL. Plasminogen carbohydrate side chains in receptor binding and enzyme activation: a study of C6 glioma cells and primary cultures of rat hepatocytes. J Cell Biochem. 1990 Jul; 43(3):213-27. PMID: 1696276.
      View in: PubMed
    124. Humphries JE, Wheby MS, VandenBerg SR. Fluoxetine and the bleeding time. Arch Pathol Lab Med. 1990 Jul; 114(7):727-8. PMID: 2363631.
      View in: PubMed
    125. VandenBerg SR, Britt SG, Redpath GT, Gonias SL. 5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets. Biochem Pharmacol. 1989 Dec 1; 38(23):4237-44. PMID: 2597195.
      View in: PubMed
    126. Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Arch Neurol. 1989 Oct; 46(10):1149-52. PMID: 2552969.
      View in: PubMed
    127. Hall SW, VandenBerg SR, Gonias SL. Expression of plasminogen receptors on C6 glioma cells. Brain Res. 1989 Aug 28; 495(2):373-6. PMID: 2548675.
      View in: PubMed
    128. Gonias SL, Braud LL, Geary WA, VandenBerg SR. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood. 1989 Aug 1; 74(2):729-36. PMID: 2546631.
      View in: PubMed
    129. Hubbard CM, Redpath GT, Macdonald TL, VandenBerg SR. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex. Brain Res. 1989 May 1; 486(1):170-4. PMID: 2541870.
      View in: PubMed
    130. Bertholf RL, Herman MM, Savory J, Carpenter RM, Sturgill BC, Katsetos CD, Vandenberg S, Wills MR. A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol Appl Pharmacol. 1989 Mar 15; 98(1):58-74. PMID: 2648649.
      View in: PubMed
    131. Hall SW, VandenBerg SR. Solid phase extraction of the zwitterionic detergent chaps. Prep Biochem. 1989; 19(1):1-11. PMID: 2740288.
      View in: PubMed
    132. VandenBerg SR, Gonias SL. Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets. Life Sci. 1989; 44(23):1777-85. PMID: 2733551.
      View in: PubMed
    133. Britt SG, Gonias SL, Sanders JM, Vandenberg S. Agonist and antagonist activities of arylpiperazines at human platelet serotonin2 receptors. J Pharmacol Exp Ther. 1988 Dec; 247(3):965-70. PMID: 3204525.
      View in: PubMed
    134. Stanton C, Perentes E, Phillips L, VandenBerg SR. The immunohistochemical demonstration of early perineurial change in the development of localized hypertrophic neuropathy. Hum Pathol. 1988 Dec; 19(12):1455-7. PMID: 2847973.
      View in: PubMed
    135. Vandenberg S, Herman MM, Rubinstein LJ. Embryonal central neuroepithelial tumors: current concepts and future challenges. Cancer Metastasis Rev. 1987; 5(4):343-65. PMID: 2882864.
      View in: PubMed
    136. VandenBerg SR, May EE, Rubinstein LJ, Herman MM, Perentes E, Vinores SA, Collins VP, Park TS. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile gangliogliomas"). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg. 1987 Jan; 66(1):58-71. PMID: 3097276.
      View in: PubMed
    137. Grady MS, Vandenberg S, Jane JA. Long term survival of a patient with an intracranial ependymoma: case report. Neurosurgery. 1986 Apr; 18(4):451-3. PMID: 3703215.
      View in: PubMed
    138. Weaver D, Vandenberg S, Park TS, Jane JA. Selective peripancreatic sarcoma metastases from primary gliosarcoma. Case report. J Neurosurg. 1984 Sep; 61(3):599-601. PMID: 6747700.
      View in: PubMed
    139. VandenBerg SR, Allgren RL, Todd RD, Ciaranello RD. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes. Proc Natl Acad Sci U S A. 1983 Jun; 80(11):3508-12. PMID: 6574495; PMCID: PMC394074.
    140. Ramsay PB, VandenBerg SR, Eng LF, Herman MM, Rubinstein LJ. Immunologic recognition of cell surface antigens in normal mouse neural tissues and in neuroepithelial cells of the OTT-6050 mouse teratoma. A radiometric, gel electrophoretic and morphologic (immunofluorescence and immunoperoxidase) study. Acta Neuropathol. 1982; 56(3):214-24. PMID: 7200313.
      View in: PubMed
    141. DeArmond SJ, VandenBerg SR, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: effects of intracerebral environment on the neural differentiation of embryoid bodies. Virchows Arch A Pathol Anat Histol. 1981; 393(1):39-52. PMID: 7347442.
      View in: PubMed
    142. Erdelyi E, VandenBerg SR, Raese J, Barchas JD, Rubinstein LJ, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma: enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells. Virchows Arch A Pathol Anat Histol. 1981; 393(1):27-37. PMID: 6126948.
      View in: PubMed
    143. VandenBerg SR, Chatel M, Griffiths OM, DeArmond SJ, Pappas C, Herman MM. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction restricted to stem cells and neural cells after centrifugal elutriation. Virchows Arch A Pathol Anat Histol. 1981; 392(3):281-94. PMID: 7269228.
      View in: PubMed
    144. VandenBerg SR, Hess JR, Herman MM, DeArmond SJ, Halks-Miller M, Rubinstein LJ. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction showing melanogenesis in neuroepithelial cells after centrifugal elutriation. Virchows Arch A Pathol Anat Histol. 1981; 392(3):295-308. PMID: 7269229.
      View in: PubMed
    145. Choie DD, Friedberg EC, VandenBerg SR, Herman MM. Non-histone chromosomal proteins in mouse brain at different stages of development and in a transplantable mouse teratoma. J Neurochem. 1977 Nov; 29(5):811-7. PMID: 591958.
      View in: PubMed
    146. VandenBerg SR, Hickey JE, Herman MM. Brain-associated cell surface antigens on neuroepithelial cells in a transplantable mouse teratoma. Acta Neuropathol. 1977 Aug 31; 39(3):281-7. PMID: 333858.
      View in: PubMed
    147. Wada HG, VandenBerg SR, Sussman HH, Grove WE, Herman MM. Characterization of two different alkaline phosphatases in mouse teratoma: partial purification, electrophoretic, and histochemical studies. Cell. 1976 Sep; 9(1):37-44. PMID: 987856.
      View in: PubMed
    148. VandenBerg SR, Ludwin SK, Herman MM, Bignami A. In vitro astrocytic differentiation from embryoid bodies of an experimental mouse testicular teratoma. Am J Pathol. 1976 Apr; 83(1):197-212. PMID: 776002; PMCID: PMC2032439.
    149. Orenberg EK, Vandenberg S, Barchas JD, Herman MM. Neurochemical studies in a mouse teratoma with neuroepithelial differentiation. Presence of cyclic AMP, serotonin and enzymes of the serotonergic, adrenergic and cholinergic systems. Brain Res. 1976 Jan 16; 101(2):273-81. PMID: 1140.
      View in: PubMed
    150. Herman MM, Sipe JC, Rubinstein LJ, Vandenberg S, Spence AM, Vraa-Jensen J. An experimental mouse testicular teratoma as a model for neuroepithelial neoplasia and differentiation. II. Electron microscopy. Am J Pathol. 1975 Nov; 81(2):421-44. PMID: 171962; PMCID: PMC2032223.
    151. Spence AM, Vandenberg S, Herman MM. Intracisternal A-particles in transplantable murine teratomas. Beitr Pathol. 1975 Aug; 155(4):428-34. PMID: 1180813.
      View in: PubMed
    152. VandenBerg SR, Herman MM, Ludwin SK, Bignami A. An experimental mouse testicular teratoma as a model for neuroepithelial neoplasia and differentiation. I. Light microscopic and tissue and organ culture observations. Am J Pathol. 1975 Apr; 79(1):147-68. PMID: 164776; PMCID: PMC1912641.
    Scott's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP